Sharemaestro Newsreel

A Look at Avantor Inc (AVTR) After 3.1% Gain -- GF Value $16.96 vs Price $13.59

Avantor Inc (AVTR) shares increased by 3.1% to $13.59, trading below its GF Value™ of $16.96, suggesting it is 19.9% undervalued. Despite being cash-flow-negative, the company holds an above-average GF Score™ of 67/100, with strong valuation but weak growth. Insider buying activity of $0.1M …

AtriCure (ATRC) director Maggie Yuen reports sale of 3,500 shares

AtriCure director Maggie Yuen sold 3,500 shares of Common Stock on August 5, 2026, at a weighted average price of $38.42 per share, totaling approximately $134,470. The shares were sold in multiple trades ranging from $38.37 to $38.43, and she now directly holds 14,015 …

AtriCure Inc (ATRC) Director Karen Prange Sells 3,564 Shares

AtriCure Inc (ATRC) Director Karen Prange sold 3,564 shares of the company on August 5, 2026, for a total value of approximately $138,283. This sale contributes to a pattern of 14 insider sells and no buys over the past year. The stock is currently …

Anteris Technologies Global (AVR) Projected to Announce Earnings on Friday

Anteris Technologies Global (AVR) is projected to announce its Q2 2026 earnings before the market opens on Friday, August 14th, with analysts expecting a loss of $0.2073 per share and revenue of $1.50 million. The company missed estimates in its previous quarter and currently …

PULSE BIOSCIENCES, INC. 2026: Revenue $434K, EPS ($0.36) — 10-Q Summary

PULSE BIOSCIENCES, INC. reported product revenue of $434K and a net loss of ($24.66M) or diluted loss per share of ($0.36) for the current quarter of 2026. This compares to no product revenue and a ($19.17M) net loss or ($0.28) per share in the …

An AtriCure Director Sold $905,000 in Stock. Here's How to Read It

Key Points Karen Prange disposed of 3,564 shares for a total transaction value of approximately $138,283 on August 5. The sale resulted in a 14% reduction in the director's total direct equity holdings in the company. All transacted shares were held directly; the director …

Embecta forecasts $1.80-$1.90 FY2026 adjusted EPS while raising adjusted operating margin to 23.5%-24%

Earnings Call Insights: Embecta (EMBC) Q3 fiscal 2026 MANAGEMENT VIEW * "During the third quarter, Embecta generated total revenue of approximately $272 million" and "on a sequential basis, our third quarter financial performance improved significantly with revenue increasing approximately $50 million" (President, CEO & …

Dentsply Sirona Reports $898 Million in Net Sales for Second Quarter 2026

Dentsply Sirona reported net sales of $898 million for the second quarter of 2026, alongside an adjusted earnings per share of $0.52. Despite a 13.2% decline in its orthodontic and implant segment sales, the company maintained its full-year financial outlook, projecting net sales between …

Nexgel Inc expected to post a loss of 12 cents a share - Earnings Preview

Nexgel Inc is anticipated to report a loss of 12 cents per share, according to this earnings preview. The article, sourced from Reuters, provides a brief update on the company's expected financial performance. Readers can find the full article and more financial news on …

Form 8K Microbot Medical Inc For: 7 August By Investing.com

This article announces that Microbot Medical Inc. filed a Form 8K on August 7th. The brief piece includes a stock symbol (MBOT) and its current price performance (+5.00%). The main content simply reiterates the filing and provides a link to view comments.

Insider Selling: Weyco Group (NASDAQ:WEYS) VP Sells $109,554.93 in Stock

Weyco Group (NASDAQ:WEYS) VP Allison Woss sold 2,511 shares of the company's stock for approximately $109,555, reducing her direct ownership by 22.47%. The transaction was disclosed in an SEC filing, and following the sale, Woss directly owns 8,663 shares. The company's shares traded up …

Stocks Settle Higher as a Weak Jobs Report Allays Rate Hike Fears

The S&P 500 Index ($SPX) (SPY) closed up +0.62% on Friday, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.28%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +1.19%. September E-mini S&P futures (ESU26) rose +0.55%, and September E-mini Nasdaq futures (NQU26) …

Bausch Lomb (BLCO) investor plans sale of 12,500 common shares

A shareholder of Bausch Lomb Corporation (BLCO) plans to sell 12,500 common shares with an aggregate market value of $206,192.77. The shares were acquired through open market purchases in May 2025 and February 2026. As of August 7, 2026, the company has 357,165,246 common …

Tango Therapeutics (NASDAQ:TNGX) Trading Down 6.1% - What's Next?

Tango Therapeutics (NASDAQ:TNGX) experienced a 6.1% decline in its share price during midday trading, closing at $27.24 with a significant 86% decrease in trading volume compared to its average. Despite the drop, analyst sentiment remains largely positive with a "Moderate Buy" consensus and an …

Enterprise value to EBIT forward of Femasys Inc. – NASDAQ:FEMY

This article provides financial data for Femasys Inc. (NASDAQ: FEMY), specifically its enterprise value to EBIT forward. It is presented through TradingView, a platform offering market data and financial tools.

Could Zacks’ Upgrade Reveal a Shift in Cooper Companies’ (COO) Earnings Quality Narrative?

Zacks recently upgraded The Cooper Companies (COO) to a Rank #2 (Buy) due to raised earnings estimates and a stronger near-term outlook. This upgrade suggests an improved earnings profile that could attract value-focused investors, despite existing pressures like competitive pricing and segment weaknesses. The …

Marathon Digital (NASDAQ:MARA) Stock Price Down 5.3% Following Analyst Downgrade

Marathon Digital's stock (NASDAQ:MARA) dropped 5.3% after Cantor Fitzgerald lowered its price target from $14 to $12, though maintaining an "overweight" rating. The company reported a significant Q2 net loss of $611.3 million and revenue below expectations, with Bitcoin holdings also decreasing. Despite these …

Bionano Genomics, Inc. expected to post a loss of 68 cents a share - Earnings Preview

Bionano Genomics, Inc. is projected to report a loss of 68 cents per share, according to this earnings preview. The article, provided by Refinitiv and featured on TradingView News, offers a brief overview of the upcoming financial expectation for BNGO. Readers can access the …

Bausch & Lomb Corp (BLCO) awards 16,778 performance-based shares to executive

Bausch & Lomb Corp (BLCO) awarded 16,778 performance-based shares to President, GPIC, Andrew J. Stewart. These shares, part of an original grant from February 28, 2024, were earned at the 100% target level on August 5, 2026, and will vest on February 28, 2027, …

DENTSPLY SIRONA Q2 Earnings Call Highlights

Embecta Corp. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:EMBC) 2026-08-07

Embecta Corp (EMBC) reported a strong sequential recovery in Q3 fiscal 2026, with revenue increasing by approximately $50 million and adjusted operating income rising by about $21 million compared to Q2. The company raised its fiscal 2026 adjusted operating margin guidance to 23.5%-24% and …

Stevanato Group S.p.A. SEC Filing (Aug 7, 2026)

Stevanato Group S.p.A. (STVN) filed a Form 144 with the SEC on August 7, 2026, indicating a proposed sale of 4,209 ordinary shares by Citigroup Global Markets, Inc. The shares were acquired on August 6, 2026, through restricted stock vesting as payment for services …

Liraglutide combination products using Stevanato Group pen gain European approval

Stevanato Group's liraglutide-based combination products, utilizing their Alina pen injector platform, have received marketing authorizations in Europe. The approvals are for Alina 30, designed for diabetes therapies, and Alina 50, intended for weight management applications, both part of a broader variable-dose platform for injectable …

ORA SURE TECHNOLOGIES INC 2026: Revenue $30.64M, Net income $6.25M, EPS $0.09— 10-Q Summary

OraSure Technologies Inc. (OSUR) reported its quarterly results for 2026, showing revenue of $30.64M, net income of $6.25M, and diluted EPS of $0.09. This represents a significant improvement compared to the prior year, which saw a net loss of ($19.69M) and an EPS of …

Medline Inc. (MDLN) major holder sells 2,248,612 shares, keeps large stake

Entities affiliated with GIC Private Ltd, GIC Special Investments Pte Ltd, and Hux Investment Pte. Ltd. sold 2,248,612 shares of Medline Inc. (MDLN) Class A Common Stock on August 5-6, 2026, at weighted-average prices in the mid-$30s. Despite the sale, these entities retain a …

Resmed Inc Stock (RMD) Closed Down by 5.22% on Aug 7: What Investors Need To Know

Resmed Inc (RMD) saw its stock close down by 5.22% on August 7th due to factors including gross margin contraction, concerns over GLP-1 weight-loss drugs impacting the CPAP market, and increased competition. The company's latest quarterly earnings revealed margin pressure from shifting product mix …

Intuitive Surgical Inc. stock underperforms Friday when compared to competitors despite daily gains

Intuitive Surgical Inc. stock (ISRG) rose 1.36% on Friday, closing at $378.81, despite the broader market also seeing gains with the S&P 500 and Dow Jones Industrial Average increasing. However, the stock still underperformed relative to its competitors, sitting 37.27% below its 52-week high …

EQUITY ACTION ALERT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC)

Faruqi & Faruqi, LLP is reminding Embecta (EMBC) investors of the August 17, 2026 deadline to seek lead plaintiff status in a securities class action lawsuit. The lawsuit alleges that Embecta made misleading statements regarding its financial guidance, particularly its pen needle business, which …

Bausch & Lomb (NYSE: BLCO) CLO earns 33,557 performance-based shares

Robert D. Bailey, EVP & Chief Legal Officer of Bausch & Lomb Corp (NYSE: BLCO), was awarded 33,557 common shares from performance stock units that achieved 100% of their target conditions as of August 5, 2026. These shares are scheduled to vest on February …

Becton, Dickinson's Fiscal Q3 Results Show Progress Amid Major Headwinds, RBC Says

RBC Capital Markets highlighted Becton, Dickinson and Company's fiscal third-quarter results as indicative of progress despite significant economic challenges. The firm acknowledged the company's efforts in managing headwinds like foreign exchange and inflation, which were largely offset by strong operational performance and effective cost …

OraSure Technologies (NASDAQ: OSUR) swings to Q2 profit as $22.5M obligation falls

Kestra Medical Technologies (NASDAQ: KMTS) insider plans sale of 26,287 shares via Form 144

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) insider Vaseem Mahboob has filed a Form 144 to sell 26,287 shares of common stock, valued at approximately $680,383.99, through Merrill Lynch. These shares originate from performance share unit awards that vested on July 14, 2026. The filing …

AustralianSuper Pty Ltd reveals 5.71% holding in ResMed Inc (NYSE: RMD)

AustralianSuper Pty Ltd has disclosed a significant passive ownership stake of 5.71% in ResMed Inc. This holding amounts to 8,276,381 ordinary shares, over which AustralianSuper Pty Ltd maintains sole voting and dispositive power. The disclosure was made via a Schedule 13G filing, indicating an …

Embecta Corp (EMBC) (Q3 2026) Earnings Call Highlights: Strong Sequential Recovery and Raised ...

Embecta Corp (EMBC) reported a strong sequential recovery in Q3 fiscal 2026, with revenue increasing by approximately $50 million and adjusted operating income rising by about $21 million compared to Q2. The company raised its fiscal 2026 adjusted operating margin guidance to 23.5%-24% and …

Vaalco Energy Inc (NYSE:EGY) to Issue $0.06 Quarterly Dividend

Vaalco Energy Inc (NYSE:EGY) has declared a quarterly dividend of $0.0625 per share, payable on September 22nd to shareholders of record on August 21st. This results in an annualized dividend of $0.25 and a yield of approximately 4.4%. While the dividend is currently covered …

Form 8K Pulse Biosciences Inc For: 6 August By Investing.com

This article announces the filing of a Form 8K by Pulse Biosciences Inc. on August 6th. The brief notice from Investing.com indicates that the information pertains to the company's financial activities or significant events as required by the SEC.